In summary, HSC alleviated inflammatory symptoms in COPD mice by suppressing the NF-κB/MAPK signaling pathways overactivation and reducing the expression of smoking-associated factors, including MMP9, MMP12, MUC-5AC, and MUC-5B. Here, MMP9 is linked to chronic obstructive pulmonary disease.